Expanded Structure–Activity Studies of Lipoxazolidinone Antibiotics
- 28 February 2019
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 10 (3) , 374-377
Abstract
The lipoxazolidinone family of marine natural products, which contains an unusual 4-oxazolidinone core, was found to possess potent antimicrobial activity against methicillin resistant Staphylococcus aureus (MRSA). Herein, we expanded our previous synthetic efforts by preparing selected aryl derivatives of the lipoxazolidinones and further evaluating the potential to expand the activity of this class of molecules to Gram-negative pathogens. With these analogs, we explored the effect of varying the substitution pattern around the aromatic ring, increasing the chain length between the oxazolidinone core and the aryl system, and how altering the position of more polar functional groups affected the antimicrobial activity. Finally, we utilized a TolC knockout strain of E. coli to demonstrate that our compounds are subject to efflux in Gram-negative pathogens, and activity is restored in these knockouts. Together these results provide additional data for the further development of 4-oxazolidinone analogs 5, 20, and 21 for the treatment of infectious disease.Keywords
Funding Information
- North Carolina State University
- National Institute of General Medical Sciences (1R01GM110154)
- Chancellor’s Innovation Fund, North Carolina State University
This publication has 23 references indexed in Scilit:
- The Evolving Role of Chemical Synthesis in Antibacterial Drug DiscoveryAngewandte Chemie International Edition, 2014
- New natural products as new leads for antibacterial drug discoveryBioorganic & Medicinal Chemistry Letters, 2014
- Latent antibiotics and the potential of the arylomycins for broad-spectrum antibacterial activityMedChemComm, 2012
- Combating Antimicrobial Resistance: Policy Recommendations to Save LivesClinical Infectious Diseases, 2011
- Synoxazolidinone C; a bicyclic member of the synoxazolidinone family with antibacterial and anticancer activitiesTetrahedron Letters, 2011
- Linezolid, the first oxazolidinone antibacterial agentAnnals of the New York Academy of Sciences, 2011
- Synoxazolidinones A and B: Novel Bioactive Alkaloids from the Ascidian Synoicum pulmonariaOrganic Letters, 2010
- Seawater requirement for the production of lipoxazolidinones by marine actinomycete strain NPS8920Journal of Industrial Microbiology and Biotechnology, 2008
- Structural and Initial Biological Analysis of Synthetic Arylomycin A2Journal of the American Chemical Society, 2007
- Lipoxazolidinones A, B, and C: Antibacterial 4-Oxazolidinones from a Marine Actinomycete Isolated from a Guam Marine SedimentJournal of Natural Products, 2007